Are alternative access pathways the key to success for small pharma in European markets?
Authors: Katrin Falk, Karlien Van den Eynde, and Anna-Karin Bostrom
Recognizing this challenge, our team of Market Access and Healthcare Consulting experts embarked on a research project to identify alternative access routes that could provide viable options for small pharma companies. The results of our study, presented at the ISPOR Europe 2023 conference by Katrin Falk, Anna-Karin Bostrom and Karlien Van den Eynde, shed light on the availability and potential benefits of these alternative pathways.
To address the resource-intensive nature of standard HTA processes for reimbursement, some countries have implemented alternative/abbreviated access pathways (AAPs). These AAPs aim to ensure local patient access to important therapeutic options while alleviating the burden on small pharma companies.
Our team of experts initiated research to assess 13 European markets for existing AAPs, summarizing their differences and similarities.
AAPs exist in most European markets, particularly benefiting small and mid-sized companies with flexible data requirements. However, it was observed that smaller markets tend to exhibit greater flexibility in implementing them compared to their larger counterparts. Unfortunately, the potential benefits offered by these alternative pathways are often overlooked or underestimated.
Download the poster to learn more unlock opportunities for streamlined market entry strategies.
This article and the poster referenced herein is intended to communicate Cencora’s capabilities which are backed by the authors’ expertise. However, Cencora strongly encourages readers to review the references provided with this article and the poster and all available information related to the topics mentioned therein and to rely on their own experience and expertise in making decisions related thereto.
Authors:
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.